| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |